Cellev8, a leading provider of Superoxide Dismutase (SOD) gummies, and Zyppah, the innovator of patented anti-snoring devices, have joined forces in a groundbreaking collaborative sales agreement.

Zyppah is the creator of FDA-cleared, clinically proven anti-snoring devices. With a 91% success rate in clinical trials, Zyppah's patented tongue stabilization technology has helped nearly a million ...

The Zyppah hybrid oral appliance is a new device that takes a different approach to treating snoring and sleep apnea. Developed by a biomedical engineer and dentist who has studied sleep apnea and ...

Zyppah has become the #1 marketed anti-snoring device and has been granted the necessary clearances by the FDA to be made available OTC (over-the-counter). Back in 2019, Zyppah and its creator, Dr.

New Jersey, United States, Dec 09, 2022 /DigitalJournal/ Anti-snoring devices are devices designed to help reduce or eliminate snoring. Typically worn at night while sleeping, they are designed to ...

The impact of snoring-related inflammation can lead to various health issues: Increased risk of cardiovascular diseases, diabetes, and neurodegenerative conditions. Higher levels of C-reactive protein ...

Cellev8 and Zyppah Announce Collaborative Sales Agreement Targeting 90 Million Snoring Americans. WELLINGTON, FL / ACCESSWIRE / October 29, 2024 / Cellev8 and Zyppah Announce Collaborative Sales ...